116 related articles for article (PubMed ID: 11741177)
1. Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide.
Basso D; Valerio A; Seraglia R; Mazza S; Piva MG; Greco E; Fogar P; Gallo N; Pedrazzoli S; Tiengo A; Plebani M
Pancreas; 2002 Jan; 24(1):8-14. PubMed ID: 11741177
[TBL] [Abstract][Full Text] [Related]
2. An unidentified pancreatic cancer cell product alters some intracellular pathways of glucose metabolism in isolated rat hepatocytes.
Basso D; Valerio A; Brigato L; Panozzo MP; Miola M; Lucca T; Ujka F; Zaninotto M; Avogaro A; Plebani M
Pancreas; 1997 Aug; 15(2):132-8. PubMed ID: 9260197
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic cancer-associated diabetes mellitus: an open field for proteomic applications.
Basso D; Greco E; Fogar P; Pucci P; Flagiello A; Baldo G; Giunco S; Valerio A; Navaglia F; Zambon CF; Pedrazzoli S; Plebani M
Clin Chim Acta; 2005 Jul; 357(2):184-9. PubMed ID: 15946661
[TBL] [Abstract][Full Text] [Related]
4. Maldi-TOF analysis of portal sera of pancreatic cancer patients: identification of diabetogenic and antidiabetogenic peptides.
Valerio A; Basso D; Fogar P; Falconi M; Greco E; Bassi C; Seraglia R; Abu-Hilal M; Navaglia F; Zambon CF; Gallo N; Falda A; Pedrazzoli S; Plebani M
Clin Chim Acta; 2004 May; 343(1-2):119-27. PubMed ID: 15115683
[TBL] [Abstract][Full Text] [Related]
5. Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: a low molecular weight factor possibly involved.
Valerio A; Basso D; Brigato L; Ceolotto G; Baldo G; Tiengo A; Plebani M
Biochem Biophys Res Commun; 1999 Apr; 257(2):622-8. PubMed ID: 10198261
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of MALDI-TOF/MS identification of low-MW fragments in sera for the differential diagnosis of pancreatic cancer.
Padoan A; Seraglia R; Basso D; Fogar P; Sperti C; Moz S; Greco E; Marchet A; de Manzoni G; Zambon CF; Navaglia F; Cristadoro L; Di Chiara A; Nitti D; Pedrazzoli S; Pavanello G; Plebani M
Pancreas; 2013 May; 42(4):622-32. PubMed ID: 23271396
[TBL] [Abstract][Full Text] [Related]
7. Serum protein profiles of patients with pancreatic cancer and chronic pancreatitis: searching for a diagnostic protein pattern.
Valerio A; Basso D; Mazza S; Baldo G; Tiengo A; Pedrazzoli S; Seraglia R; Plebani M
Rapid Commun Mass Spectrom; 2001; 15(24):2420-5. PubMed ID: 11746913
[TBL] [Abstract][Full Text] [Related]
8. Characterization of apolipoprotein and apolipoprotein precursors in pancreatic cancer serum samples via two-dimensional liquid chromatography and mass spectrometry.
Chen J; Anderson M; Misek DE; Simeone DM; Lubman DM
J Chromatogr A; 2007 Aug; 1162(2):117-25. PubMed ID: 17434173
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
Navaglia F; Fogar P; Basso D; Greco E; Padoan A; Tonidandel L; Fadi E; Zambon CF; Bozzato D; Moz S; Seraglia R; Pedrazzoli S; Plebani M
Clin Chem Lab Med; 2009; 47(6):713-23. PubMed ID: 19426140
[TBL] [Abstract][Full Text] [Related]
10. Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes.
Basso D; Millino C; Greco E; Romualdi C; Fogar P; Valerio A; Bellin M; Zambon CF; Navaglia F; Dussini N; Avogaro A; Pedrazzoli S; Lanfranchi G; Plebani M
Gut; 2004 Aug; 53(8):1159-66. PubMed ID: 15247186
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic protein discovery using proteolytic peptide targeting and identification.
Koomen JM; Zhao H; Li D; Abbruzzese J; Baggerly K; Kobayashi R
Rapid Commun Mass Spectrom; 2004; 18(21):2537-48. PubMed ID: 15468157
[TBL] [Abstract][Full Text] [Related]
12. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
13. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
14. Peptidomics-based approach reveals the secretion of the 29-residue COOH-terminal fragment of the putative tumor suppressor protein DMBT1 from pancreatic adenocarcinoma cell lines.
Sasaki K; Sato K; Akiyama Y; Yanagihara K; Oka M; Yamaguchi K
Cancer Res; 2002 Sep; 62(17):4894-8. PubMed ID: 12208737
[TBL] [Abstract][Full Text] [Related]
15. Conditioned Medium from Malignant Breast Cancer Cells Induces an EMT-Like Phenotype and an Altered N-Glycan Profile in Normal Epithelial MCF10A Cells.
Guo J; Liu C; Zhou X; Xu X; Deng L; Li X; Guan F
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763000
[TBL] [Abstract][Full Text] [Related]
16. Specific amino acid profile in culture media conditioned by human pancreatic cancer cell lines.
Wang F; Permert J
Pancreatology; 2002; 2(4):402-6. PubMed ID: 12138229
[TBL] [Abstract][Full Text] [Related]
17. Identification of Small Proteins and Peptides in the Differentiation of Patients with Intraductal Mucinous Neoplasms of the Pancreas, Chronic Pancreatitis and Pancreatic Adenocarcinoma.
Fania C; Pezzilli R; Melzi d'Eril G; Gelfi C; Barassi A
Dig Dis Sci; 2018 Apr; 63(4):920-933. PubMed ID: 29417328
[TBL] [Abstract][Full Text] [Related]
18. Separation of six uremic middle molecular compounds by high performance liquid chromatography and analysis by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Chu J; Yuan Z; Liu X; Wu Q; Mi H; He B
Clin Chim Acta; 2001 Sep; 311(2):95-107. PubMed ID: 11566169
[TBL] [Abstract][Full Text] [Related]
19. A simple and rapid method for identifying and semi-quantifying peptide hormones in isolated pancreatic islets by direct-tissue matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
Stewart KW; Phillips AR; Whiting L; Jüllig M; Middleditch MJ; Cooper GJ
Rapid Commun Mass Spectrom; 2011 Nov; 25(22):3387-95. PubMed ID: 22002691
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of two novel peptide safety markers for exocrine pancreatic toxicity.
Walgren JL; Mitchell MD; Whiteley LO; Thompson DC
Toxicol Sci; 2007 Mar; 96(1):184-93. PubMed ID: 17169977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
